Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseTBIFluid percussionC57BL/6J wild type; CD74 (invariant chain) deficient on C57BL/6 backgroundMalen = 24 h flow cytometry and multiplex: sham plus vehicle n=6, s…Intraperitoneal1 mg/kg (CAP dissolved at 5 mg/mL in DMSO, 5 microL diluted…20 minutes after fluid percussion injury
Model: Lateral fluid percussion injury through a 2 mm craniotomy over the left parietal cortex with dura intact, 12 to 16 ms pulse at approximately 1.4 to 1.6 atm
CAP given 20 minutes after fluid percussion injury reversed the injury-induced expansion of splenic lymphocyte subsets, lowered brain cytokine levels and reduced lesion size and neurodegeneration, with CD74-deficient mice showing similar protection.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.